FDA Approves Clinolipid for IV Nutrition, Easing ShortageFDA Approves Clinolipid for IV Nutrition, Easing Shortage
The new parenteral feeding product, which contains refined olive oil and refined soybean oil, is not indicated for children. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2013 Category: Consumer Health News Tags: Critical Care News Alert Source Type: news
FDA approves Clinolipid for intravenous nutrition
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 4, 2013 Category: American Health Source Type: news
PRAC Wants Numeta G13%E Off the MarketPRAC Wants Numeta G13%E Off the Market
The committee wants marketing authorization of the intravenous nutrition preparation Numeta G13%E suspended because of a risk for hypermagnesemia in premature infants. News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2013 Category: Consumer Health News Tags: Pediatrics News Alert Source Type: news
Prolacta study published in Journal of Pediatrics demonstrates lower incidence of intestinal disease in preemies fed exclusive human milk diet
Prolacta Bioscience announces that results of the double-blind study published in the Journal of Pediatrics demonstrate that extremely premature infants who are fed an exclusive human milk diet instead of preterm formula have a significantly lower incidence of surgery associated with the intestinal disease necrotizing enterocolitis (NEC) and require fewer days of intravenous feedings through total parenteral nutrition (TPN)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 2, 2013 Category: Consumer Health News Tags: Pediatrics / Children's Health Source Type: news
Intestinal failure-associated liver disease reversed in 6 months by fish oil
Children who suffer from intestinal failure, most often caused by a shortened or dysfunctional bowel, are unable to consume food orally. Instead, a nutritional cocktail of sugar, protein and fat made from soybean oil is injected through a small tube in their vein. For these children, the intravenous nutrition serves as a bridge to bowel adaptation, a process by which the intestine recovers and improves its capacity to absorb nutrition... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 16, 2013 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news
Fish oil is safe and effective in reversing liver disease in some
LOS ANGELES, Aug. 15 (UPI) -- Fish oil is safe and effective in reversing liver disease in children with intestinal failure who require intravenous nutrition, U.S. researchers say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 15, 2013 Category: Consumer Health News Source Type: news
Six months of fish oil reverses liver disease in children with intestinal failure, study shows
Children who suffer from intestinal failure, most often caused by a shortened or dysfunctional bowel, are unable to consume food orally. Instead, a nutritional cocktail of sugar, protein and fat made from soybean oil is injected through a small tube in their vein.
For these children, the intravenous nutrition serves as a bridge to bowel adaptation, a process by which the intestine recovers and improves its capacity to absorb nutrition. But the soybean oil, which provides essential fatty acids and calories, has been associated with a potentially lethal complication known as intestinal failure–associat...
Source: UCLA Newsroom: Health Sciences - August 14, 2013 Category: Universities & Medical Training Source Type: news
6 months of fish oil reverses liver disease in children with intestinal failure, study shows
(University of California - Los Angeles Health Sciences) A clinical trial conducted at the Children's Discovery and Innovation Institute at Mattel Children's Hospital UCLA has found that, compared with soybean oil, a limited duration (24 weeks) of fish oil is safe and effective in reversing liver disease in children with intestinal failure who require intravenous nutrition. The researchers believe that fish oil may also decrease the need for liver and/or intestinal transplants -- and mortality -- associated with this disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2013 Category: Global & Universal Source Type: news
Evidence update on nutrition support in adults
The new evidence update focuses on a summary of selected new evidence relevant to NICE clinical guideline 32: Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (February 2006). (Source: NHS Networks)
Source: NHS Networks - August 12, 2013 Category: UK Health Authors: Maria Axford Source Type: news
Ethanol Locks for Catheter Infection in Parenteral NutritionEthanol Locks for Catheter Infection in Parenteral Nutrition
Ethanol locks help prevent catheter-related bloodstream infection (CRBSI) in patients on home parenteral nutrition (HPN), a recent study suggests. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Once daily injection of teduglutide offers hope for short-bowel syndrome patients
A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal failure who are reliant on intravenous nutrition, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Patients with this relatively rare condition experience massive bowel loss and are unable to absorb nutrients, vitamins and water from digested foods. They rely on parenteral nutrition, or intravenous feeding, to deliver their daily nutrients... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 22, 2013 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news
Guiding Stem Cells With Magnets
Magnets could be a tool for directing stem cells' healing powers to treat conditions such as heart disease or vascular disease. By feeding stem cells tiny particles made of magnetized iron oxide, scientists at Emory and Georgia Tech can then use magnets to attract the cells to a particular location in a mouse's body after intravenous injection. The results are published online in the journal Small and will appear in an upcoming issue. The paper was a result of collaboration between the laboratories of W. Robert Taylor, MD, PhD, and Gang Bao, PhD... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 18, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news
New treatment offers hope for short-bowel syndrome patients
(American Gastroenterological Association) A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal failure who are reliant on intravenous nutrition, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 18, 2013 Category: Global & Universal Source Type: news
Scientifically Based Strategies for Enteral Feeding in Premature Infants
This article discusses controversies regarding the enteral feeding of very low birthweight infants and includes current scientific evidence supporting and/or refuting specific feeding practices. (Source: NeoReviews recent issues)
Source: NeoReviews recent issues - July 1, 2013 Category: Pediatrics Authors: Parker, L. A., Neu, J., Torrazza, R. M., Li, Y. Tags: Articles Source Type: news
Antihistamines may increase pregnancy risks for women with severe morning sickness
Women with a severe form of morning sickness who take antihistamines to help them sleep through their debilitating nausea are significantly more likely to experience premature births or have low–birth-weight babies, a UCLA study has found.
The findings, the first to link antihistamine use to adverse pregnancy outcomes, are important because babies born at 37 weeks or earlier often are hospitalized longer than full-term babies, can experience problems breathing and feeding, are more prone to infection and can suffer from developmental problems. Women with morning sickness who are considering taking such medicat...
Source: UCLA Newsroom: Health Sciences - June 12, 2013 Category: Universities & Medical Training Source Type: news
